Skip to main content
. 2012 Nov 13;5(4):207–212. doi: 10.3342/ceo.2012.5.4.207

Table 3.

Multivariate analysis for combinations of p16, p53, and EGFR for recurrence-free survival

graphic file with name ceo-5-207-i003.jpg

HPV, human papillomavirus; EGFR, epidermal growth factor receptor.

*First model included age, sex, T stage, N stage, smoking, treatment, HPV DNA, EGFR, and p16(+)/p53(-). Second model included age, sex, T stage, N stage, smoking, treatment, HPV DNA, p53(-) and p16(+)/EGFR(-). Third model included age, sex, T stage, N stage, smoking, treatment, HPV DNA, p16(+), and p53(-)/EGFR(-).